| Product Code: ETC7753272 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Arteriovenous Malformations (AVMs) Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Arteriovenous Malformations (AVMs) Market - Industry Life Cycle |
3.4 Jordan Arteriovenous Malformations (AVMs) Market - Porter's Five Forces |
3.5 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Arteriovenous Malformations (AVMs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about arteriovenous malformations (AVMs) in Jordan |
4.2.2 Technological advancements in diagnostic tools and treatment options for AVMs |
4.2.3 Growing healthcare infrastructure and availability of specialized medical professionals in Jordan |
4.3 Market Restraints |
4.3.1 High treatment costs associated with AVM diagnosis and management |
4.3.2 Limited access to advanced medical facilities in certain regions of Jordan |
4.3.3 Regulatory challenges related to approvals and reimbursement for AVM treatments |
5 Jordan Arteriovenous Malformations (AVMs) Market Trends |
6 Jordan Arteriovenous Malformations (AVMs) Market, By Types |
6.1 Jordan Arteriovenous Malformations (AVMs) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By True Arteriovenous Malformation, 2021- 2031F |
6.1.4 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Occult or Cryptic, 2021- 2031F |
6.1.5 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Cavernous Malformations, 2021- 2031F |
6.1.6 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Venous Malformation, 2021- 2031F |
6.1.7 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hemangioma, 2021- 2031F |
6.1.8 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Dural Fistula, 2021- 2031F |
6.2 Jordan Arteriovenous Malformations (AVMs) Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage I (Quiescence), 2021- 2031F |
6.2.3 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage II (Expansion), 2021- 2031F |
6.2.4 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage III (Destruction), 2021- 2031F |
6.2.5 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Stage IV (Decompensation), 2021- 2031F |
6.2.6 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Arteriovenous Malformations (AVMs) Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.3.3 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.4 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.5 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Jordan Arteriovenous Malformations (AVMs) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Jordan Arteriovenous Malformations (AVMs) Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 Jordan Arteriovenous Malformations (AVMs) Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Arteriovenous Malformations (AVMs) Market Import-Export Trade Statistics |
7.1 Jordan Arteriovenous Malformations (AVMs) Market Export to Major Countries |
7.2 Jordan Arteriovenous Malformations (AVMs) Market Imports from Major Countries |
8 Jordan Arteriovenous Malformations (AVMs) Market Key Performance Indicators |
8.1 Average time taken for AVM diagnosis and treatment initiation |
8.2 Number of healthcare facilities offering specialized AVM treatments in Jordan |
8.3 Patient satisfaction scores with AVM treatment outcomes |
9 Jordan Arteriovenous Malformations (AVMs) Market - Opportunity Assessment |
9.1 Jordan Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Jordan Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Jordan Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Jordan Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Jordan Arteriovenous Malformations (AVMs) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Arteriovenous Malformations (AVMs) Market - Competitive Landscape |
10.1 Jordan Arteriovenous Malformations (AVMs) Market Revenue Share, By Companies, 2024 |
10.2 Jordan Arteriovenous Malformations (AVMs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here